Clinical Trials Browser

Phase 3 × Carcinoma, Hepatocellular × Nivolumab × Clear all

Carcinoma, Hepatocellular

NCT04157985 2025-12-11

Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors

DermatologicGastrointestinalGenitourinaryGynecologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Anus Neoplasms, Urinary Bladder Neoplasms, Uterine Cervical Neoplasms, Carcinoma, Hepatocellular, Kidney Neoplasms, Melanoma, Stomach Neoplasms, Colorectal Neoplasms, Carcinoma, Merkel Cell, Cholangiocarcinoma

NCT03383458 2025-11-21

CheckMate 9DX

Phase 3 Active not recruiting

545 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT02576509 2025-02-17

An Investigational Immuno-therapy Study of Nivolumab Compared to Sorafenib as a First Treatment in Patients With Advanced Hepatocellular Carcinoma

Phase 3 Completed

743 enrolled 16 charts

Gastrointestinal

Carcinoma, Hepatocellular

Clinical Trials

CheckMate 9DW

Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors

CheckMate 9DX

An Investigational Immuno-therapy Study of Nivolumab Compared to Sorafenib as a First Treatment in Patients With Advanced Hepatocellular Carcinoma